Loading

DealSize | PK - News

لوحة التحكم

الأخبار
التقويم
ChartDS

التسعير
الوسطاء

كيف يمكنني مساعدتك؟

الأسئلة المقترحة:

مدى اليوم

الإغلاق السابق

مدى 52 أسبوعًا

الحد الأقصى للسوق

حجم

EPS الأساسي (TTM)

نسبة PE

نظرة عامة تقنيون الاستراتيجيات الشؤون المالية الأخبار

News

PureTech Founded Entity Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress

GuruFocus9 أكتوبر 2026

PureTech Founded Entity Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress

Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress

GuruFocus9 أكتوبر 2026

Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress

Park Hotels & Resorts Inc. Successfully Repays the $1.275 Billion CMBS Loan Secured by the Hilton Hawaiian Village Resort

Business Wire30 سبتمبر 2026

Park Hotels & Resorts Inc. Successfully Repays the $1.275 Billion CMBS Loan Secured by the Hilton Hawaiian Village Resort

PK

Park Hotels & Resorts Inc.

PKNYSE

$15.17-$0.04(0.26%)اعتبارا من أمس في 20:00 UTC

حول Park Hotels & Resorts Inc.

القطاع

Real Estate

الصناعة

REIT - Hotel & Motel

البلد

US

الموقع

www.pkhotelsandresorts.com

Park Hotels & Resorts Inc. operates as the second-largest publicly traded real estate investment trust (REIT) focused on the lodging sector. It manages a diversified collection of 60 premium-branded hotels and resorts, which are market leaders and possess considerable underlying real estate value. These properties include over 33,000 guest rooms, predominantly situated in prime urban centers and popular resort destinations.